# Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

> **NCT06603753** · — · NOT_YET_RECRUITING · sponsor: **alaa aboelhassan mohamed aboelhassan** · enrollment: 80 (estimated)

## Conditions studied

- Hyperbilirubinemia, Neonatal

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06603753
- **Lead sponsor:** alaa aboelhassan mohamed aboelhassan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06603753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06603753, "Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06603753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*